These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9134274)

  • 61. The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters.
    Zehetgruber M; Beckmann R; Gabriel H; Christ G; Binder BR; Huber K
    Thromb Res; 1996 Jul; 83(2):143-52. PubMed ID: 8837313
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of imidapril and candesartan cilexetil on plasminogen activator inhibitor-1 expression induced by prolonged inhibition of nitric oxide synthesis in rat hearts.
    Katoh M; Egashira K; Mitsui T; Takeshita A; Narita H
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):932-6. PubMed ID: 10836729
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.
    Gray RP; Patterson DL; Yudkin JS
    Arterioscler Thromb; 1993 Mar; 13(3):415-20. PubMed ID: 8443145
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The renin-angiotensin system and fibrinolysis.
    Vaughan DE
    Am J Cardiol; 1997 Mar; 79(5A):12-6. PubMed ID: 9127616
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Angiotensin-converting enzyme inhibition and fibrinolytic balance.
    Matsumoto T; Horie M
    Hypertens Res; 2011 Apr; 34(4):448-9. PubMed ID: 21326308
    [No Abstract]   [Full Text] [Related]  

  • 66. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
    Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
    J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
    Higashi Y; Sasaki S; Nakagawa K; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2001 Mar; 37(3):863-70. PubMed ID: 11693763
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction.
    Soejima H; Ogawa H; Yasue H; Kaikita K; Takazoe K; Nishiyama K; Misumi K; Miyamoto S; Yoshimura M; Kugiyama K; Nakamura S; Tsuji I
    J Am Coll Cardiol; 1999 Oct; 34(4):983-8. PubMed ID: 10520779
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.
    Pahor M; Franse LV; Deitcher SR; Cushman WC; Johnson KC; Shorr RI; Kottke-Marchant K; Tracy RP; Somes GW; Applegate WB
    Circulation; 2002 Jan; 105(4):457-61. PubMed ID: 11815428
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systemic, regional and cerebral hemodynamic effects of a new angiotensin converting enzyme inhibitor, imidapril, in healthy volunteers.
    Démolis P; Annane D; Duhazé P; Giudicelli JF
    Fundam Clin Pharmacol; 1994; 8(1):80-9. PubMed ID: 8181800
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Magnesium therapy, fibrinolytic parameters and von Willebrand factor in acute myocardial infarction.
    Thögersen AM; Jansson JH; Wester PO
    Int J Cardiol; 1996 Sep; 56(1):53-9. PubMed ID: 8891805
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
    Kobayashi N; Hara K; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Defective fibrinolysis occurs after infrainguinal reconstruction.
    Killewich LA; Macko RF; Gardner AW; Cox K; Lilly MP; Flinn WR
    J Vasc Surg; 1997 May; 25(5):858-64; discussion 865. PubMed ID: 9152313
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Handa S; Abe S; Takahashi E; Watanabe K; Hori S; Ikeda Y
    Cardiology; 1993; 82(4):280-5. PubMed ID: 8402755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study.
    Munkvad S; Jespersen J; Gram J; Kluft C
    J Am Coll Cardiol; 1991 Mar; 17(4):957-62. PubMed ID: 1900313
    [TBL] [Abstract][Full Text] [Related]  

  • 78. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria.
    Gasic S; Wagner OF; Fasching P; Ludwig C; Veitl M; Kapiotis S; Jilma B
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):217-22. PubMed ID: 10090351
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
    Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.